Ameriprise’s Vertex Pharmaceuticals VRTX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $971M | Sell |
2,181,362
-54,107
| -2% | -$24.1M | 0.24% | 87 |
|
2025
Q1 | $1.08B | Buy |
2,235,469
+219,946
| +11% | +$107M | 0.29% | 67 |
|
2024
Q4 | $812M | Buy |
2,015,523
+143,713
| +8% | +$57.9M | 0.21% | 99 |
|
2024
Q3 | $871M | Sell |
1,871,810
-182,971
| -9% | -$85.1M | 0.22% | 93 |
|
2024
Q2 | $963M | Sell |
2,054,781
-170,526
| -8% | -$79.9M | 0.26% | 78 |
|
2024
Q1 | $930M | Sell |
2,225,307
-284,722
| -11% | -$119M | 0.26% | 82 |
|
2023
Q4 | $1.02B | Sell |
2,510,029
-427,783
| -15% | -$174M | 0.31% | 65 |
|
2023
Q3 | $1.02B | Sell |
2,937,812
-86,031
| -3% | -$29.9M | 0.34% | 59 |
|
2023
Q2 | $1.06B | Sell |
3,023,843
-366,017
| -11% | -$129M | 0.33% | 62 |
|
2023
Q1 | $1.07B | Sell |
3,389,860
-188,787
| -5% | -$59.5M | 0.35% | 57 |
|
2022
Q4 | $1.03B | Sell |
3,578,647
-463,346
| -11% | -$134M | 0.35% | 60 |
|
2022
Q3 | $1.17B | Sell |
4,041,993
-520,956
| -11% | -$151M | 0.43% | 41 |
|
2022
Q2 | $1.29B | Sell |
4,562,949
-384,414
| -8% | -$108M | 0.45% | 40 |
|
2022
Q1 | $1.29B | Buy |
4,947,363
+524,167
| +12% | +$137M | 0.38% | 50 |
|
2021
Q4 | $969M | Buy |
4,423,196
+1,034,106
| +31% | +$227M | 0.27% | 74 |
|
2021
Q3 | $615M | Buy |
3,389,090
+650,315
| +24% | +$118M | 0.2% | 111 |
|
2021
Q2 | $552M | Buy |
2,738,775
+820,708
| +43% | +$165M | 0.17% | 129 |
|
2021
Q1 | $412M | Buy |
1,918,067
+1,100,467
| +135% | +$236M | 0.14% | 161 |
|
2020
Q4 | $193M | Sell |
817,600
-22,268
| -3% | -$5.26M | 0.07% | 296 |
|
2020
Q3 | $228M | Sell |
839,868
-444,227
| -35% | -$121M | 0.09% | 231 |
|
2020
Q2 | $373M | Sell |
1,284,095
-888,799
| -41% | -$258M | 0.16% | 136 |
|
2020
Q1 | $517M | Sell |
2,172,894
-236,171
| -10% | -$56.2M | 0.27% | 73 |
|
2019
Q4 | $527M | Buy |
2,409,065
+30,299
| +1% | +$6.63M | 0.22% | 91 |
|
2019
Q3 | $403M | Sell |
2,378,766
-62,955
| -3% | -$10.7M | 0.18% | 114 |
|
2019
Q2 | $448M | Buy |
2,441,721
+78,258
| +3% | +$14.4M | 0.2% | 103 |
|
2019
Q1 | $435M | Sell |
2,363,463
-1,986,539
| -46% | -$365M | 0.2% | 100 |
|
2018
Q4 | $721M | Sell |
4,350,002
-1,393,382
| -24% | -$231M | 0.36% | 51 |
|
2018
Q3 | $1.11B | Sell |
5,743,384
-82,081
| -1% | -$15.8M | 0.39% | 49 |
|
2018
Q2 | $988M | Buy |
5,825,465
+220,446
| +4% | +$37.4M | 0.44% | 39 |
|
2018
Q1 | $914M | Buy |
5,605,019
+349,639
| +7% | +$57M | 0.41% | 42 |
|
2017
Q4 | $787M | Sell |
5,255,380
-176,700
| -3% | -$26.5M | 0.36% | 56 |
|
2017
Q3 | $826M | Sell |
5,432,080
-973,672
| -15% | -$148M | 0.39% | 49 |
|
2017
Q2 | $826M | Sell |
6,405,752
-1,832,449
| -22% | -$236M | 0.41% | 42 |
|
2017
Q1 | $901M | Sell |
8,238,201
-468,434
| -5% | -$51.2M | 0.47% | 35 |
|
2016
Q4 | $641M | Buy |
8,706,635
+11,204
| +0.1% | +$825K | 0.35% | 53 |
|
2016
Q3 | $758M | Sell |
8,695,431
-328,644
| -4% | -$28.7M | 0.42% | 43 |
|
2016
Q2 | $776M | Sell |
9,024,075
-379,072
| -4% | -$32.6M | 0.45% | 43 |
|
2016
Q1 | $747M | Sell |
9,403,147
-187,047
| -2% | -$14.9M | 0.45% | 44 |
|
2015
Q4 | $1.21B | Sell |
9,590,194
-571,203
| -6% | -$71.9M | 0.71% | 26 |
|
2015
Q3 | $1.06B | Buy |
10,161,397
+286,836
| +3% | +$29.9M | 0.66% | 26 |
|
2015
Q2 | $1.22B | Sell |
9,874,561
-81,333
| -0.8% | -$10M | 0.69% | 19 |
|
2015
Q1 | $1.17B | Buy |
9,955,894
+642,075
| +7% | +$75.7M | 0.67% | 23 |
|
2014
Q4 | $1.11B | Sell |
9,313,819
-184,044
| -2% | -$21.9M | 0.64% | 22 |
|
2014
Q3 | $1.07B | Buy |
9,497,863
+2,419,288
| +34% | +$272M | 0.64% | 21 |
|
2014
Q2 | $670M | Sell |
7,078,575
-1,047,185
| -13% | -$99.1M | 0.4% | 46 |
|
2014
Q1 | $575M | Buy |
8,125,760
+334,295
| +4% | +$23.6M | 0.35% | 63 |
|
2013
Q4 | $579M | Buy |
7,791,465
+1,833,313
| +31% | +$136M | 0.35% | 59 |
|
2013
Q3 | $452M | Buy |
5,958,152
+1,375,662
| +30% | +$104M | 0.3% | 65 |
|
2013
Q2 | $366M | Buy |
+4,582,490
| New | +$366M | 0.25% | 81 |
|